Merck KGaA (MKKGY) Projected to Post Earnings on Thursday

Merck KGaA (OTCMKTS:MKKGY) is anticipated to post its results before the market opens on Thursday, November 12th. Analysts expect the company to announce earnings of $0.50 per share and revenue of $6.12 billion for the quarter.

Merck KGaA Stock Down 0.1%

OTCMKTS:MKKGY opened at $33.73 on Wednesday. The firm’s 50-day moving average price is $31.68 and its 200-day moving average price is $30.05. The company has a market capitalization of $21.80 billion, a PE ratio of 17.41, a P/E/G ratio of 2.93 and a beta of 0.92. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.69 and a quick ratio of 1.09. Merck KGaA has a 1-year low of $23.73 and a 1-year high of $34.19.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on MKKGY. Zacks Research cut shares of Merck KGaA from a “hold” rating to a “strong sell” rating in a research report on Monday, October 12th. UBS Group cut shares of Merck KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 20th. Five analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Reduce”.

About Merck KGaA

Merck KGaA is a German science and technology company headquartered in Darmstadt. Founded in 1668, it traces its origins to a pharmacy established by the Merck family and has grown into a global business serving customers in healthcare, research and industry. It is separate from the U.S.-based Merck & Co. The company operates through three main businesses. Its Healthcare division develops and markets prescription medicines, including treatments in areas such as oncology, neurology and fertility.